|
|
|
Friday, February 10, 2012
|
Issue 3
|
VOLUME 1
ISSUE 3
|
|
|
|
SEARCH
|
|
dtSearch Web Search
|
|
|  |
 |
 |
The Use of Pergolide May Be Linked to Changes in Heart Valves
Previously published reports have identified a limited number of cases of abnormalities in the heart valves of patients who have taken pergolide. In a study that was published in the journal Lancet in April 2004, researchers examined all patients with Parkinson's disease in their clinic and found that the connection between the use of pergolide and damage to heart valves was more common than previously thought to be.
[FULL STORY]
|
Results from a Preliminary Study of the Use of Glial Cell-Line Derived Neurotrophic Factor in Parkinson's Disease Hold Promise
In a report presented at the American Academy of Neurology meeting in San Francisco, researchers provided the results of a preliminary study of the treatment of Parkinson's disease with glial cell-line derived neurotrophic factor (GNDF). In this two-year study, the five patients showed improved scores on a subjective rating scale and increased density in dopamine transporters on imaging studies. GDNF is a protein that the body requires in order to create, maintain, and grow nerve cells.
[FULL STORY]
|
The Chat Rooms Are Open
Did you know that WE MOVE has chat rooms? WE MOVE provides this service to allow for the free exchange of information and ideas among various movement disorder communities, including patients, families, and caregivers. Find support, encouragement, and information on a variety of topics, including dystonia, essential tremor, Parkinson’s disease, corticobasal degeneration, spasmodic dysphonia, Sydenham’s chorea, and tardive dyskinesia. We also have chat rooms for musicians with dystonia and parents of children with movement disorders (the Parent-to-Parent chat). The chat rooms at WE MOVE are always open, so stop in any time.
|
|
|
Supported by an educational grant from the Medtronic Foundation
Published by
Copyright © 2004 WE MOVE. All rights reserved.
|
|
|
|
Judith Blazer, Executive Director, WE MOVE
Meghan Murphy, CME and Communications Coordinator
Edited by Richard Robinson, Cate Murray and Joy Leffler
| |